12Jul 2024
Butyrate and Tributyrin Reduce Visceral Fat Inflammation

Butyrate and Tributyrin Reduce Visceral Fat Inflammation

The obesity crisis has led to chronic inflammation in individuals with excess visceral fat due to cytokine and chemokine release. This study aimed to find anti-inflammatory agents to mitigate this inflammation. Using a protocol for incubating human visceral adipose tissue with low-dose lipopolysaccharide (LPS), researchers identified sodium butyrate and tributyrin as effective agents. Both significantly reduced LPS-induced inflammatory cytokine production and were non-toxic at tested concentrations. RNA-Seq analysis highlighted IL-36γ as a key gene affected by these agents. The findings suggest sodium butyrate and tributyrin could alleviate chronic inflammation in obese individuals.

  • #endo-diabetology

Like

Save

Share